State Substitution Laws and Uptake of an Interchangeable Insulin Biosimilar
In this cohort study, insulin users in states with less restrictive substitution laws were more likely to fill the biosimilar alternative to insulin glargine, underscoring the role of state regulations of substitution as an important determinant of biosimilar adoption and the need for reforms to increase efficient biosimilar adoption.
Authors
- Ameet Sarpatwari (ORCID: https://orcid.org/0000-0001-5043-6206)
- Youngmin Kwon (ORCID: https://orcid.org/0000-0001-8037-5758)
- Stacie B. Dusetzina (ORCID: https://orcid.org/0000-0002-3907-9196)
Institutions
- Harvard University (US)
- Harvard Pilgrim Health Care (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1001/jamahealthforum.2025.0406
- Citations
- 2
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 1.59